DE3481169D1 - Galenische formen des sulpirids zur oralen verabreichung. - Google Patents

Galenische formen des sulpirids zur oralen verabreichung.

Info

Publication number
DE3481169D1
DE3481169D1 DE8484402308T DE3481169T DE3481169D1 DE 3481169 D1 DE3481169 D1 DE 3481169D1 DE 8484402308 T DE8484402308 T DE 8484402308T DE 3481169 T DE3481169 T DE 3481169T DE 3481169 D1 DE3481169 D1 DE 3481169D1
Authority
DE
Germany
Prior art keywords
sulpirid
oral administration
galenic forms
sulpiride
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484402308T
Other languages
English (en)
Inventor
Patrice Debregeas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE PARIS FR Ste
Original Assignee
D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE PARIS FR Ste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE PARIS FR Ste filed Critical D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE PARIS FR Ste
Application granted granted Critical
Publication of DE3481169D1 publication Critical patent/DE3481169D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
DE8484402308T 1983-11-14 1984-11-13 Galenische formen des sulpirids zur oralen verabreichung. Expired - Lifetime DE3481169D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8318003A FR2554718B1 (fr) 1983-11-14 1983-11-14 Nouvelles formes galeniques du sulpiride utilisables par voie orale

Publications (1)

Publication Number Publication Date
DE3481169D1 true DE3481169D1 (de) 1990-03-08

Family

ID=9294045

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484402308T Expired - Lifetime DE3481169D1 (de) 1983-11-14 1984-11-13 Galenische formen des sulpirids zur oralen verabreichung.

Country Status (8)

Country Link
EP (1) EP0145558B1 (de)
AT (1) ATE49883T1 (de)
AU (1) AU3613984A (de)
CA (1) CA1226818A (de)
DE (1) DE3481169D1 (de)
FR (1) FR2554718B1 (de)
WO (1) WO1985002114A1 (de)
ZA (1) ZA848894B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
DE4332394A1 (de) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
CN1169857A (zh) * 1996-07-10 1998-01-14 林东和 降眼压活性组合物
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
FR2494112B1 (de) * 1980-11-19 1986-01-10 Laruelle Claude
FR2534139B1 (fr) * 1982-10-07 1986-08-29 Laruelle Claude Nouvelle forme galenique du sulpiride, son procede de preparation et medicament comprenant cette nouvelle forme

Also Published As

Publication number Publication date
ATE49883T1 (de) 1990-02-15
EP0145558B1 (de) 1990-01-31
ZA848894B (en) 1985-11-27
CA1226818A (fr) 1987-09-15
FR2554718B1 (fr) 1986-04-04
WO1985002114A1 (fr) 1985-05-23
EP0145558A3 (en) 1985-08-07
AU3613984A (en) 1985-06-03
FR2554718A1 (fr) 1985-05-17
EP0145558A2 (de) 1985-06-19

Similar Documents

Publication Publication Date Title
CA2231525A1 (en) Nutritional support of paediatric patients
NO882762L (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske forbindelser.
NO871790D0 (no) Fremgangsmaate for fremstilling av et oralt farmasoeytisk preparat.
NO882200L (no) Fremgangsmaate for fremstilling av kalsiumsulfat-alfa-halvhydrat.
DE3766200D1 (de) L-dopa enthaltendes arzneimittel.
GR3005768T3 (de)
EA199600029A2 (ru) Оральная композиция, содержащая s(+)-этодолак, способ ее получения
NO881643L (no) Fremgangsmaate for fremstilling av hoeystabile mykgelatinkapsler for terapeutiske formaal.
NO162619C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive l-aminosyre-derivater
DE3481169D1 (de) Galenische formen des sulpirids zur oralen verabreichung.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO870104D0 (no) Farmasoeytisk preparat med vedvarende frigivelse av den aktive komponenten og fremgangsmaate for fremstilling derav.
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
EP0425298A3 (en) Sustained-release preparation of basic medical agent hydrochloride
AU563822B2 (en) Pharmaceutical composition of piroxicam and 5'-guanylic acid or n-acetyl-l-methionine
ES8502332A1 (es) Un procedimiento de preparacion de nuevas formas galenicas de n-(etil-1-pirrolidinil-2-)-metil-metoxi-2-sulfamoil-5-benzamida, utilizables por via oral
SE8701077L (sv) Farmaceutisk beredning
DE3676491D1 (de) Gelatinekapseln mit gesteuerter wirkstofffreisetzung und verfahren zur herstellung derselben.
NO841372L (no) Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig regulert frigjoering
AU2542884A (en) Immunogenic deteminants of foot and mouth disease virus
AU613060B2 (en) Hexapeptide and pharmaceutical preparation based thereon for curing erosive-ulcerous injuries to the digestive tract
EP0383481A3 (de) Bukkale Anästhetika
DE3773716D1 (de) Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
NO884792D0 (no) Fremgangsmaate for fremstilling av alfa-olefinpolymer.
DE3382348D1 (de) Tablette in form einer kapsel, verfahren und apparat fuer ihre herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition